Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - OPERATING INCOME
Operating Income PRPH - ProPhase Labs, Inc.
-21.6 M
LAST VALUE
-79.03%
2 YEAR CAGR
-67.61%
5 YEAR CAGR
-48.73%
10 YEAR CAGR